THE NATIONAL COUNCIL OF THE SR APPROVED AMENDMENTS TO THE ACT ON NARCOTICS, PSYCHOTROPIC SUBSTANCES AND PREPARATIONS
Photo: NR SR
On November 8, 2022, the National Council of the Slovak Republic approved the Government’s draft law amending Act No. 139/1998 Coll. on narcotic substances, psychotropic substances and preparations as amended (hereinafter referred to as “Act No. 139/1998 Coll.”)
The aim of the amendment of the law in question is to supplement Annex no. 1 of Act no. 139/1998 Coll. for two Group I narcotic substances based on the decision taken at the 65th session of the Commission on Narcotic Substances of the United Nations Office on Narcotic Drugs and Crime from 14 March to 18 March 2022 (UNODC – United Nations Office on Drugs and Crime). This decision was made based on the evaluation of the expert committee on drug addiction of the World Health Organization. Furthermore, it was proposed to include the substance euthylone as a group I psychotropic substance, which the Slovak Republic has already classified as a group I psychotropic substance, so this bill does not propose to include it in the list of psychotropic substances.
In the current annex – the list of narcotic substances and psychotropic substances, another 15 psychoactive substances were included, of which four substances (“benzylone”, “brorfin”, “methonitazene”, “salvinorin A”) belong to the I. group of narcotic substances, eight substances (” ADB – Butinaca’, ‘alpha-PhiP’, ‘AL-LAD’, ‘Icp-LSD’, ‘3-FEA’, ‘IPPH, IPH, IPD, IPPD’, ‘N-ethylpentedrone’, ‘O-PCE’ to the II. group of psychotropic substances and the other three substances (“phenibut”, “Xylazine” clarification of the wording “poppy straw concentrate”) to the II. group of narcotic substances.
Amendment of Act No. 139/1998 Coll. it is to be effective from December 1, 2022 and aims to contribute to the increase of social protection of the population and has a significant potential in the prevention of addictions to the use of narcotic substances and psychotropic substances, including the prevention of treatment of health consequences of persons addicted to the use of narcotic substances and psychotropic substances.
PUBLISHED: November 08, 2022